chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Headache, Influenza like illness, Myalgia
Clinical narrative: Dry cough; Shortness of breath; Fever-I don't remember how high; Body aches all over; Nausea; Headaches; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Dry cough), DYSPNOEA (Shortness of breath), PYREXIA (Fever-I don't remember how high) and MYALGIA (Body aches all over) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL [SALBUTAMOL] and BECLOMETASONE DIPROPIONATE (QVAR) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Fever-I don't remember how high), MYALGIA (Body aches all over), NAUSEA (Nausea) and HEADACHE (Headaches). On 07-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath). On an unknown date, the patient experienced COUGH (Dry cough). On 05-Mar-2021, NAUSEA (Nausea) had resolved. On 06-Mar-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Fever-I don't remember how high) and HEADACHE (Headaches) had resolved. At the time of the report, DYSPNOEA (Shortness of breath) and MYALGIA (Body aches all over) outcome was unknown.            Treatment information were not provided.   This case was linked to MOD-2021-111314, MOD-2021-040985 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: NNI case, no new information was added
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Dry cough; Shortness of breath; Fever-I don't remember how high; Body aches all over; Nausea; Headaches; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Dry cough), DYSPNOEA (Shortness of breath), PYREXIA (Fever-I don't remember how high) and MYALGIA (Body aches all over) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL [SALBUTAMOL] and BECLOMETASONE DIPROPIONATE (QVAR) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Fever-I don't remember how high), MYALGIA (Body aches all over), NAUSEA (Nausea) and HEADACHE (Headaches). On 07-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath). On an unknown date, the patient experienced COUGH (Dry cough). On 05-Mar-2021, NAUSEA (Nausea) had resolved. On 06-Mar-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Fever-I don't remember how high) and HEADACHE (Headaches) had resolved. At the time of the report, DYSPNOEA (Shortness of breath) and MYALGIA (Body aches all over) outcome was unknown.            Treatment information were not provided.   This case was linked to MOD-2021-111314, MOD-2021-040985 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: NNI case, no new information was added
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Rash, Vaccination site erythema, Vaccination site warmth
Clinical narrative: woke up with a red arm (where I got vaccinated), very hot (almost like a rash); rash; red arm; fatigue; fever; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (woke up with a red arm (where I got vaccinated), very hot (almost like a rash)), RASH (rash), PYREXIA (fever), VACCINATION SITE ERYTHEMA (red arm) and FATIGUE (fatigue) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Hypothyroidism. Concomitant products included THIAMAZOLE (TAPAZOLE) for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced PYREXIA (fever). On 10-May-2021, the patient experienced VACCINATION SITE WARMTH (woke up with a red arm (where I got vaccinated), very hot (almost like a rash)), RASH (rash), VACCINATION SITE ERYTHEMA (red arm) and FATIGUE (fatigue). The patient was treated with LORATADINE at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 08-May-2021, PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE WARMTH (woke up with a red arm (where I got vaccinated), very hot (almost like a rash)), RASH (rash), VACCINATION SITE ERYTHEMA (red arm) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was about to start radioactive iodine treatment. The patient took Loratadine and 1 Advil.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (Fever). At the time of the report, CHILLS (chills) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pre-existing condition improved, Therapeutic response unexpected
Clinical narrative: The lungs did not bring up much phlegm's like before; Breathing problems improved like after receiving the steroid shot; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (The lungs did not bring up much phlegm's like before) and PRE-EXISTING CONDITION IMPROVED (Breathing problems improved like after receiving the steroid shot) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Bronchitis (Underlying lungs problem) since January 2020.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (The lungs did not bring up much phlegm's like before) and PRE-EXISTING CONDITION IMPROVED (Breathing problems improved like after receiving the steroid shot). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (The lungs did not bring up much phlegm's like before) and PRE-EXISTING CONDITION IMPROVED (Breathing problems improved like after receiving the steroid shot) outcome was unknown.            Concomitant medicines include Inhalers for Bronchitis Patient wants to Thank each and everyone of Moderna team member's for the wonderful job Action taken with mRNA-1273 in response to the event was not applicable
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash macular, Swelling
Clinical narrative: swelling; red spot; itching; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), RASH MACULAR (red spot) and PRURITUS (itching) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03610BA) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced SWELLING (swelling), RASH MACULAR (red spot) and PRURITUS (itching). The patient was treated with HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. On 07-May-2021, SWELLING (swelling) and RASH MACULAR (red spot) had resolved. At the time of the report, PRURITUS (itching) had not resolved. Not provided.          Patient called to report adverse reaction. Moderna COVID-19 vaccine administered on 5May2021, after which patient reports that their arm started itching, became swollen and had a big red spot for 2 days after. Patient states that arm continues to be itchy at time of call, redness and swelling resolved. Patient is wondering if they should receive booster vaccine in alternate arm. Second dose information: 006C21A, expiration date unknown, administered on 5May2021 in left arm.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on her chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her chest) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 04-May-2021, the patient experienced RASH (Rash on her chest). At the time of the report, RASH (Rash on her chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment include steroid cream which has helped the patient with itching. No other medication reported.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Vomiting
Clinical narrative: Bruising on feet, back and arms; Vomitting; This spontaneous case was reported by a patient and describes the occurrence of VOMITING (Vomitting) and CONTUSION (Bruising on feet, back and arms) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced VOMITING (Vomitting). On an unknown date, the patient experienced CONTUSION (Bruising on feet, back and arms). At the time of the report, VOMITING (Vomitting) and CONTUSION (Bruising on feet, back and arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Feeling abnormal, Feeling of body temperature change, Head discomfort, Myalgia
Clinical narrative: Feeling really bad all day; Feels cold and warm at the same time; Her bones hurt; Her head hurts like stitches; Pain all over body; Arm hurts; Swollen; Purple where the picket is; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Pain all over body), FEELING ABNORMAL (Feeling really bad all day), FEELING OF BODY TEMPERATURE CHANGE (Feels cold and warm at the same time), BONE PAIN (Her bones hurt) and PAIN IN EXTREMITY (Arm hurts) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts), SWELLING (Swollen) and SKIN STRIAE (Purple where the picket is). On 11-May-2021, the patient experienced MYALGIA (Pain all over body), FEELING ABNORMAL (Feeling really bad all day), FEELING OF BODY TEMPERATURE CHANGE (Feels cold and warm at the same time), BONE PAIN (Her bones hurt) and HEAD DISCOMFORT (Her head hurts like stitches). At the time of the report, MYALGIA (Pain all over body), FEELING ABNORMAL (Feeling really bad all day), FEELING OF BODY TEMPERATURE CHANGE (Feels cold and warm at the same time), BONE PAIN (Her bones hurt), PAIN IN EXTREMITY (Arm hurts), SWELLING (Swollen), SKIN STRIAE (Purple where the picket is) and HEAD DISCOMFORT (Her head hurts like stitches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Skin striae, Swelling
Clinical narrative: Feeling really bad all day; Feels cold and warm at the same time; Her bones hurt; Her head hurts like stitches; Pain all over body; Arm hurts; Swollen; Purple where the picket is; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Pain all over body), FEELING ABNORMAL (Feeling really bad all day), FEELING OF BODY TEMPERATURE CHANGE (Feels cold and warm at the same time), BONE PAIN (Her bones hurt) and PAIN IN EXTREMITY (Arm hurts) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts), SWELLING (Swollen) and SKIN STRIAE (Purple where the picket is). On 11-May-2021, the patient experienced MYALGIA (Pain all over body), FEELING ABNORMAL (Feeling really bad all day), FEELING OF BODY TEMPERATURE CHANGE (Feels cold and warm at the same time), BONE PAIN (Her bones hurt) and HEAD DISCOMFORT (Her head hurts like stitches). At the time of the report, MYALGIA (Pain all over body), FEELING ABNORMAL (Feeling really bad all day), FEELING OF BODY TEMPERATURE CHANGE (Feels cold and warm at the same time), BONE PAIN (Her bones hurt), PAIN IN EXTREMITY (Arm hurts), SWELLING (Swollen), SKIN STRIAE (Purple where the picket is) and HEAD DISCOMFORT (Her head hurts like stitches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Experienced minor muscle aches one day after second Covid-19 injection injection; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Experienced minor muscle aches one day after second Covid-19 injection injection) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Experienced minor muscle aches one day after second Covid-19 injection injection). At the time of the report, MYALGIA (Experienced minor muscle aches one day after second Covid-19 injection injection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Action taken with mRNA( COVID-19 Vaccine) was not applicable No concomitant medications were reported Treatment includes two ibuprofen pills to treat his minor muscle pain
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Inappropriate schedule of product administration
Clinical narrative: shingles outbreak; 2nd dose scheduled for today (11May2021), 1st dose 21 days ago; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles outbreak) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose scheduled for today (11May2021), 1st dose 21 days ago) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to drug dulaglutide.).    On 11-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles outbreak) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose scheduled for today (11May2021), 1st dose 21 days ago). The patient was treated with VALACYCLOVIR HYDROCHLORIDE ongoing since an unknown date for Herpes zoster, at an unspecified dose and frequency and PREDNISONE ongoing since an unknown date for Herpes zoster, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles outbreak) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose scheduled for today (11May2021), 1st dose 21 days ago) outcome was unknown.            The information about concomitant products was declined
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Product dose omission issue, Urinary tract infection
Clinical narrative: UTI; bedridden; Product dose omission issue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (UTI), BEDRIDDEN (bedridden) and PRODUCT DOSE OMISSION ISSUE (Product dose omission issue) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 040A21A,) for COVID-19 vaccination.    Co-suspect product included non-company product PALBOCICLIB (IBRANCE) for Cancer.    No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started PALBOCICLIB (IBRANCE) (Oral) 100 milligram once a day. In April 2021, the patient experienced BEDRIDDEN (bedridden) and PRODUCT DOSE OMISSION ISSUE (Product dose omission issue). On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI) and BEDRIDDEN (bedridden) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Product dose omission issue) had resolved.            Treatment and concomitant medications were not provided by reporter.   This case was linked to MOD-2021-121339, MOD-2021-121339 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medicines and concomitant medicines were not reported
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headaches that started 2 weeks after the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (headaches that started 2 weeks after the vaccine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches that started 2 weeks after the vaccine). At the time of the report, HEADACHE (headaches that started 2 weeks after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products were not provided Treatment medication were not reported   Reporter did not allow further contact
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Headache, Pain in extremity
Clinical narrative: Loss of taste; Possibly have covid-19 virus; Loss of smell; Headache; Chills; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm), AGEUSIA (Loss of taste), SUSPECTED COVID-19 (Possibly have covid-19 virus), ANOSMIA (Loss of smell) and HEADACHE (Headache) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021 at 8:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm) and HEADACHE (Headache). 11-May-2021, the patient experienced CHILLS (Chills). On 12-May-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). 12-May-2021, the patient experienced SUSPECTED COVID-19 (Possibly have covid-19 virus). On 13-May-2021, AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) had resolved. At the time of the report, PAIN IN EXTREMITY (Soreness in arm), SUSPECTED COVID-19 (Possibly have covid-19 virus), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, SARS-CoV-2 test: negative (Negative) Negative.         No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: No specific follow-up information recorded.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: Loss of taste; Possibly have covid-19 virus; Loss of smell; Headache; Chills; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm), AGEUSIA (Loss of taste), SUSPECTED COVID-19 (Possibly have covid-19 virus), ANOSMIA (Loss of smell) and HEADACHE (Headache) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021 at 8:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm) and HEADACHE (Headache). 11-May-2021, the patient experienced CHILLS (Chills). On 12-May-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). 12-May-2021, the patient experienced SUSPECTED COVID-19 (Possibly have covid-19 virus). On 13-May-2021, AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) had resolved. At the time of the report, PAIN IN EXTREMITY (Soreness in arm), SUSPECTED COVID-19 (Possibly have covid-19 virus), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, SARS-CoV-2 test: negative (Negative) Negative.         No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: No specific follow-up information recorded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea
Clinical narrative: nausea; tired; achy; This spontaneous case was reported by a pharmacist and describes the occurrence of NAUSEA (nausea), FATIGUE (tired) and MYALGIA (achy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced NAUSEA (nausea), FATIGUE (tired) and MYALGIA (achy). At the time of the report, NAUSEA (nausea), FATIGUE (tired) and MYALGIA (achy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was given. No laboratory details was given. No treatment information was given. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash macular
Clinical narrative: redness; big red round spot; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (big red round spot) and ERYTHEMA (redness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 047B21A) for COVID-19 vaccination.     No history was provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], DULOXETINE, PROGESTERONE, METOPROLOL, OMEPRAZOLE, ASCORBIC ACID (VITAMIN C ACID), ZINC, LACTOBACILLUS REUTERI (PROBIOTICA) and METHYLCELLULOSE (CITRUCEL) for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH MACULAR (big red round spot). On 06-May-2021, the patient experienced ERYTHEMA (redness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, RASH MACULAR (big red round spot) and ERYTHEMA (redness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No laboratory details was given. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up information received on 12 May 2021 contains non-significant information.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Asthenia, Asthenopia, Fatigue, Headache
Clinical narrative: Sore arm; Could not tolerate the smell of food; Lost my sense of taste; Could not keep my eyes open; Fatigue; Nagging headache; Weak; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Sore arm), PAROSMIA (Could not tolerate the smell of food) and AGEUSIA (Lost my sense of taste) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Sore arm), PAROSMIA (Could not tolerate the smell of food), AGEUSIA (Lost my sense of taste), ASTHENOPIA (Could not keep my eyes open), FATIGUE (Fatigue) and HEADACHE (Nagging headache). At the time of the report, ASTHENIA (Weak), PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Sore arm), PAROSMIA (Could not tolerate the smell of food), AGEUSIA (Lost my sense of taste), ASTHENOPIA (Could not keep my eyes open), FATIGUE (Fatigue) and HEADACHE (Nagging headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-123338 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-123338:Wife's case
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Parosmia, Peripheral swelling
Clinical narrative: Sore arm; Could not tolerate the smell of food; Lost my sense of taste; Could not keep my eyes open; Fatigue; Nagging headache; Weak; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Sore arm), PAROSMIA (Could not tolerate the smell of food) and AGEUSIA (Lost my sense of taste) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Sore arm), PAROSMIA (Could not tolerate the smell of food), AGEUSIA (Lost my sense of taste), ASTHENOPIA (Could not keep my eyes open), FATIGUE (Fatigue) and HEADACHE (Nagging headache). At the time of the report, ASTHENIA (Weak), PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Sore arm), PAROSMIA (Could not tolerate the smell of food), AGEUSIA (Lost my sense of taste), ASTHENOPIA (Could not keep my eyes open), FATIGUE (Fatigue) and HEADACHE (Nagging headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-123338 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-123338:Wife's case
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness
Clinical narrative: Woozy/lightheaded; Sick to the stomach; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Woozy/lightheaded) and ABDOMINAL DISCOMFORT (Sick to the stomach) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concomitant products included LORAZEPAM for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced DIZZINESS (Woozy/lightheaded) and ABDOMINAL DISCOMFORT (Sick to the stomach). At the time of the report, DIZZINESS (Woozy/lightheaded) and ABDOMINAL DISCOMFORT (Sick to the stomach) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant product use included blood pressure and cholesterol medications for unspecified indications. Treatment information was not provided. Patient provided consent to follow up. Patient reported she was feeling well and does not have any symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Narrative updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure increased, Chills, Headache, Myalgia
Clinical narrative: Headache; chills; joint pain in legs; muscle aches in thighs; blood pressure 160/140; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 13-May-2021 and was forwarded to Moderna on 13-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (blood pressure 160/140), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (joint pain in legs) and MYALGIA (muscle aches in thighs) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044a21a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy ((some) Penicillin, sulfa, beta blockers, Angiotensin receptor blockers), Congestive heart failure (Congestive heart failure-left ventricle), Blood pressure high, Diabetes, Hyperlipidemia and Acute otitis media with effusion. Concomitant products included CANDESARTAN, CARVEDILOL, LEVOTHYROXINE SODIUM (SYNTHROID), METFORMIN, PANTOPRAZOLE, FOLIC ACID, EZETIMIBE (EZETIM), POTASSIUM CHLORIDE (KLOR-CON M20), CYANOCOBALAMIN (NASCOBAL), FLUTICASONE PROPIONATE (FLUTICASONE PROPRIONATE) and COLECALCIFEROL (D-3) for an unknown indication.    On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced BLOOD PRESSURE INCREASED (blood pressure 160/140). On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (joint pain in legs) and MYALGIA (muscle aches in thighs). In April 2021, BLOOD PRESSURE INCREASED (blood pressure 160/140) had resolved. At the time of the report, HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (joint pain in legs) and MYALGIA (muscle aches in thighs) had resolved.            Treatment was not provided   This case was linked to MODERNATX, INC.-MOD-2021-051847 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-051847:First dose
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Influenza like illness, Lip blister, Pyrexia
Clinical narrative: SHORTNESS OF BREATH; fever blisters on upper lip; flu-like symptoms; Dizziness; Fever; Tender arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TENDERNESS (Tender arm), DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms) and DIZZINESS (Dizziness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0461321A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LOSARTAN, MONTELUKAST SODIUM (SINGULAIR), CLOPIDOGREL BISULFATE (PLAVIX) and HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced TENDERNESS (Tender arm). On 15-Apr-2021, the patient experienced DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (Dizziness) and PYREXIA (Fever). On 13-May-2021, DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (Dizziness) and PYREXIA (Fever) had resolved. At the time of the report, TENDERNESS (Tender arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-127725 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: SHORTNESS OF BREATH; fever blisters on upper lip; flu-like symptoms; Dizziness; Fever; Tender arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TENDERNESS (Tender arm), DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms) and DIZZINESS (Dizziness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0461321A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LOSARTAN, MONTELUKAST SODIUM (SINGULAIR), CLOPIDOGREL BISULFATE (PLAVIX) and HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced TENDERNESS (Tender arm). On 15-Apr-2021, the patient experienced DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (Dizziness) and PYREXIA (Fever). On 13-May-2021, DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (Dizziness) and PYREXIA (Fever) had resolved. At the time of the report, TENDERNESS (Tender arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-127725 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Chills, Dizziness, Fatigue
Clinical narrative: Drowsiness; Dizziness; arm pit soreness; Fatigue; Chills; shoulder soreness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue), CHILLS (Chills), ARTHRALGIA (shoulder soreness) and NAUSEA (Nausea). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) at a dose of UNK dosage form. At the time of the report, SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue), CHILLS (Chills), ARTHRALGIA (shoulder soreness) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Somnolence
Clinical narrative: Drowsiness; Dizziness; arm pit soreness; Fatigue; Chills; shoulder soreness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue), CHILLS (Chills), ARTHRALGIA (shoulder soreness) and NAUSEA (Nausea). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) at a dose of UNK dosage form. At the time of the report, SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue), CHILLS (Chills), ARTHRALGIA (shoulder soreness) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Feeling hot, Pain in extremity
Clinical narrative: Dizziness; Sore arm; Chills alternating with a feeling warm; Chills alternating with a feeling warm; Tiredness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Chills alternating with a feeling warm), CHILLS (Chills alternating with a feeling warm) and FATIGUE (Tiredness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B210 and 027421A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (allergy to codeine), Food allergy (allergy to green pepper), Food allergy (allergy to egg plant), Food allergy (allergy to parabens), Toothpaste allergy (allergy togel toothpaste), Seasonal allergy and Hypercholesterolemia. Concomitant products included ROSUVASTATIN and EZETIMIBE for Hypercholesterolemia, UBIDECARENONE (COQ10 [UBIDECARENONE]) and LUTEIN [XANTOFYL] for Supplementation therapy, CENTRUM SILVER WOMEN 50+ for Vitamin deficiency NOS.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Chills alternating with a feeling warm), CHILLS (Chills alternating with a feeling warm), FATIGUE (Tiredness) and PYREXIA (Fever). At the time of the report, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Chills alternating with a feeling warm), CHILLS (Chills alternating with a feeling warm), FATIGUE (Tiredness) and PYREXIA (Fever) had resolved.            No treatment product information was provided   This case was linked to MOD-2021-053363 (Patient Link).   Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Dizziness; Sore arm; Chills alternating with a feeling warm; Chills alternating with a feeling warm; Tiredness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Chills alternating with a feeling warm), CHILLS (Chills alternating with a feeling warm) and FATIGUE (Tiredness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B210 and 027421A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (allergy to codeine), Food allergy (allergy to green pepper), Food allergy (allergy to egg plant), Food allergy (allergy to parabens), Toothpaste allergy (allergy togel toothpaste), Seasonal allergy and Hypercholesterolemia. Concomitant products included ROSUVASTATIN and EZETIMIBE for Hypercholesterolemia, UBIDECARENONE (COQ10 [UBIDECARENONE]) and LUTEIN [XANTOFYL] for Supplementation therapy, CENTRUM SILVER WOMEN 50+ for Vitamin deficiency NOS.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Chills alternating with a feeling warm), CHILLS (Chills alternating with a feeling warm), FATIGUE (Tiredness) and PYREXIA (Fever). At the time of the report, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), FEELING HOT (Chills alternating with a feeling warm), CHILLS (Chills alternating with a feeling warm), FATIGUE (Tiredness) and PYREXIA (Fever) had resolved.            No treatment product information was provided   This case was linked to MOD-2021-053363 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Very tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced FATIGUE (Very tired).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-073234 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Magnetic at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Magnetic at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Magnetic at injection site). At the time of the report, VACCINATION SITE REACTION (Magnetic at injection site) outcome was unknown. Not Provided          Concomitant medications were not reported. Treatment information were not provided.